中文产业新闻评分67Chinese source
中国首个自主研发IL-17A/F抑制剂丽倍坦®获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.